Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Behav Med. 2022 May 25;49(4):392–401. doi: 10.1080/08964289.2022.2077295

Table 3.

Smoking Abstinence, Vaping Abstinence, and Dual Use Status for Heterosexual and Bisexual Individuals at 3, 12, and 24 Months among Responders only and ITT

Unadjusted Adjusted
Heterosexuals Bisexuals OR 95% CI p-Value AOR 95% CI p-Value
Smoking Abstinence (7 day pp, RO)
 3 months (N = 1939) 285 (16.4%) 35 (17.5%) 1.08 0.74–1.59 .69 1.19 0.79–1.79 .41
 12 months (N = 1448) 481 (37.3%) 63 (39.9%) 1.12 0.80–1.56 .53 1.08 0.75–1.55 .68
 24 months (N = 1514) 656 (48.8%) 86 (50.3%) 1.06 0.77–1.46 .72 1.03 0.74–1.45 .86
Vaping Abstinence (7 day pp, RO)
 3 months (N = 1936) 180 (10.4%) 38 (19.1%) 2.04 1.39–3.00 <0.001 1.56 1.03–2.37 .04
 12 months (N = 1444) 309 (24.0%) 38 (23.9%) 0.99 0.67–1.46 .97 0.74 0.49–1.11 .15
 24 months (N = 1516) 440 (32.7%) 59 (34.5%) 1.08 0.78–1.52 .64 0.85 0.60–1.23 .39
Dual Use Status (RO)
 3 months (N = 1936) 1284 (73.9%) 129 (64.8%) 0.65 0.48–0.89 <.01 0.70 0.50–0.97 .03
 12 months (N = 1442) 586 (45.6%) 70 (44.3%) 0.95 0.68–1.32 .75 1.16 0.81–1.66 .42
 24 months (N = 1514) 434 (32.3%) 57 (33.3%) 1.05 0.75–1.47 .79 1.23 0.86–1.77 .25
Smoking Abstinence (7 day pp, ITT)
 3 months (N = 2706) 285 (11.8%) 35 (11.9%) 1.01 0.69–1.47 .96 1.09 0.73–1.62 .68
 12 months (N = 2706) 481 (19.9%) 63 (21.4%) 1.10 0.81–1.47 .55 1.03 0.75–1.42 .84
 24 months (N = 2706) 656 (27.2%) 86 (29.3%) 1.11 0.85–1.45 .46 1.07 0.80–1.42 .67

Abbreviations: 7 day pp=7-day point-prevalence; RO=responders only; AOR=adjusted odd ratio for study condition, sex, age, and income; CI=confidence interval; ITT=Intent to treat